| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
4-Reductase Activity in Mammary Tumor-bearing Rats1
College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455
The effect of mammary tumors on steroid
4-reductase activity was investigated using in vitro and in vivo studies in three transplantable rat mammary tumors. Steroid
4-5
-reductase activity was measured spectrophotometrically and was significantly decreased in the host livers from R3230AC and MT/W9a-B but was increased in 7,12-dimethylbenz(a)anthracene-induced No. 14 tumor-bearing rats. There were no significant alterations of 5ß-reductase activity in all animals investigated. In vivo studies using [14C]testosterone showed a similar pattern for saturation of the 4,5-double bond but that the more than doubled increase in 4,5-reduced metabolites observed in the in vivo studies in 7,12-dimethylbenz(a)anthracene-induced tumor-bearing rats cannot be explained by the increase observed in hepatic enzyme activity. Incubations with mammary tumor tissues showed that 7,12-dimethylbenz(a)anthracene-induced tumors have a very active
4-5
-reductase enzyme which accounts for the observed increases in in vivo results. The surgical removal of the tumor abolishes the impairment in
4-reductase activity.
1 These investigations were supported by Grant CA 22467 from the National Cancer Institute, USPHS.
Received 8/22/80. Accepted 1/12/81.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |